Q&A: A Retired Doctor on Alzheimer’s, Faith, Hope, and Community
In our LiveTalk series, Being Patient spoke with retired physician Jennifer Bute about the early symptoms of Alzheimer’s that she began experiencing in the 2000s,…
In our LiveTalk series, Being Patient spoke with retired physician Jennifer Bute about the early symptoms of Alzheimer’s that she began experiencing in the 2000s,…
The amyloid hypothesis—the idea that Alzheimer’s is caused by clumps of proteins known as beta-amyloid—remains unproven. But scientists are holding out hope that monoclonal…
Growing evidence shows that dysfunction of the vascular system, vessels that carry blood and fluid throughout the body, is closely linked with cognitive decline…
In the future, implantable devices that interface with the brain could help people with severe neurodegenerative movement disorders communicate again through a computer or…
It has long been assumed that a person’s general cognitive ability declines as they grow older. But new research challenges this widely-held assumption, showing that…
New wearable tech is being designed to detect depression with more than twice the accuracy of your average human psychiatrist — and prompt users…
Early-onset dementia — sometimes referred to as young-onset — has long been a puzzle for doctors, scientists, and researchers alike. Initial symptoms of the…
An emerging brain technology — transcranial magnetic stimulation — offers a non-invasive way to change the brain for the better, using magnets. Proponents believe…
In our LiveTalk series, Being Patient spoke with Marc Archambault about his early symptoms of Alzheimer’s, the ways in which he has adapted his career…
Jacquelyn Revere sheds light on the challenges faced by young dementia caregivers through her incredibly popular TikTok account @MomOfMyMom. This article is part of…
Spending time with a friend or a loved one who simply listens about our day’s ups and downs can go a long way in…
The biotechnology company Eisai Co., Ltd. announced a rolling submission for accelerated approval from the Food and Drug Administration for their anti-amyloid Alzheimer’s treatment,…
Scientists are looking toward microglia cells as therapeutic targets for Alzheimer’s. Microglia, known as the janitors of our brains, are responsible for clearing harmful…
Using the blue device (pictured) that performs the ultrasensitive proximity extension assay technology, Professor Nancy Ip Yuk-Yu and her team have developed a blood…
We know that brains benefit from being put to work. Increasingly, researchers are looking at gaming and brain health. Some games are designed specifically…